News
News

The latest updates from AFAR.

Board Member in the News: David Sinclair’s New Book “Lifespan: Why We Age – and Why We Don’t Have To” published by Atria Books

Sep 27
2019

Board Member in the News: David Sinclair’s New Book “Lifespan: Why We Age – and Why We Don’t Have To” published by Atria Books

AFAR congratulates Board Member David Sinclair, PhD, AO, on the release of his book,  Lifespan: Why We Age – and Why We Don’t Have To,  published by Atria Books, a subsidiary of Simon & Schuster. In this groundbreaking book, Dr. Sinclair reveals a bold new theory for why we age. “David is a pioneer poised to change how we think about and understand aging,” AFAR Executive Director Stephanie Lederman endorses on the book’s back cover. Dr. Sinclair is a 2000 AFAR Research Grant recipient. He is also a Professor in the Department of…


View MoreREAD MORE


AFAR in the News: AFAR whitepaper by S. Jay Olshansky on healthspan of 2020 candidates in JAMA Network

Sep 21
2019

AFAR in the News: AFAR whitepaper by S. Jay Olshansky on healthspan of 2020 candidates in JAMA Network

  On September 11, 2019, JAMA Network spotlighted the recent research-backed whitepaper by AFAR expert S. Jay Olshansky, PhD,  arguing how healthspan matters more than age when considering a presidential candidate. Referencing the AFAR-published whitepaper, Longevity and Health of US Presidential Candidates for the 2020 Election, the article reinforces the whitepaper’s emphasis on healthspan, not chronological age.  “Given the candidates’ favorable health and longevity forecasts,” the article states, “‘there is reason to question whether age should be used at all in making judgments about prospective presidential candidates.’” Dr. Olshansky is on AFAR…


View MoreREAD MORE


Ask the Expert Interview: Nathan LeBrasseur on Sarcopenia, the protein Myostatin, and Exercise on Next Avenue

Sep 19
2019

Ask the Expert Interview: Nathan LeBrasseur on Sarcopenia, the protein Myostatin, and Exercise on Next Avenue

AFAR is excited to announce the latest addition to our “Ask the Expert” interview series. In this exclusive interview, AFAR expert Nathan LeBrasseur, PT, PhD lends his insights on sarcopenia, his research on the protein myostatin, and the benefits of exercise to prevent loss of muscle mass. Dr. LeBrasseur is a 2002 Glenn/AFAR Scholarship for Research in the Biology of Aging recipient, and a 2019 Vincent Cristofalo Rising Star Award in Aging Research recipient.  He is also a Consultant, Professor, and Co-Chair of Research in the Department of Physical Medicine and Rehabilitation at the Mayo Clinic. Read…


View MoreREAD MORE


Grantee in the News: Brian Kennedy on the health care crisis in Forbes

Sep 6
2019

Grantee in the News: Brian Kennedy on the health care crisis in Forbes

On August 30, 2019 Forbes featured insights from AFAR expert Brian Kennedy, PhD, on the challenge of an aging society. Dr. Kennedy positioned the health care needs of our aging population as the “climate change of healthcare,” as many of the solutions rest on changing peoples’ behavior by modifying diet and other lifestyle habits. Dr. Kennedy is a 2003 AFAR Research Grant recipient, and a 2008 Medical Student Training in Aging Research (MSTAR) program awardee. He is also a Professor at the Buck Institute for Research on Aging. Read the article, “Falling Life Expectancy Becoming The ‘Climate Change’…


View MoreREAD MORE


Board Member in the News: Nir Barzilai on TAME Trials & Metformin’s clinical impact in Healio’s Endocrine Today

Sep 6
2019

Board Member in the News: Nir Barzilai on TAME Trials & Metformin’s clinical impact in Healio’s Endocrine Today

On August 30, 2019  Healio’s Endocrine Today featured the insights of AFAR expert Nir Barzilai, MD, on the goals and benefits of the upcoming TAME trials, which will evaluate metformin’s clinical impact. Dr. Barzilai is AFAR’s Deputy Scientific Director, a 1994 AFAR Research Grant recipient, a 1997 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar, a 2010 Irving S. Wright Award winner, the  Director at the Institute for Aging Research and distinguished Professor at the Albert Einstein College of Medicine. Read the article, “Metformin may hold anti-aging promise to increase ‘health span…


View MoreREAD MORE




BACK TO TOPBACK TO TOP